Define the intended consumer and proposition
Specify who the product is for, when it is used and how the brand intends to describe it. Avoid treating every nighttime consumer need as the same formulation problem. Establish exclusions and safety-review requirements with qualified specialists before narrowing ingredients.
Choose ingredients around a clear rationale
Decide whether melatonin is in scope and identify the documentation needed for every candidate ingredient. Compare the proposed combinations with the available evidence and intended market. An ingredient's familiarity does not establish the suitability of a finished blend or the claims made for it.
Develop the routine and the format together
Capsules, gummies and drink powders create different use experiences and formulation constraints. Set the desired flavor, serving and preparation method where relevant. Package communication, timing instructions and the evidence plan should be reviewed as part of a coherent finished-product brief.
A USEFUL STARTING POINT
Bring these three decisions.
- Adult consumer and evening use occasion
- Melatonin preference and ingredient exclusions
- Format and proposed wellness positioning
PCG can scope concept definition, formulation and prototype work, sourcing, and the manufacturing handoff around your priorities. Deliverables, timing, testing and ownership terms are agreed for the project. Manufacturing is performed by the selected CDMO.
BEFORE WE BEGIN
Sleep supplement formulation: your questions.
Can PCG scope a melatonin-free sleep product?
Yes. The concept should have its own ingredient rationale, intended consumer and evidence review. Melatonin-free describes an exclusion; it does not establish an outcome.
Can a sleep formula be made as a powder?
A drink-powder concept can be explored around the serving, taste and evening preparation ritual. The format still needs compatibility, manufacturing and stability work.
Can we claim the product treats insomnia?
That is not an appropriate default for a dietary-supplement development brief. Disease-related positioning requires specialist regulatory assessment; PCG starts with a clearly defined wellness scope.